$1.84
-0.06-3.16%
At close: -
$1.89
0.052.72%
After Hours: 7:49 PM EDT
Comments
Loading...
Latest Inhibikase Therapeutics Stock News | NASDAQ:IKT | Benzinga
Get the latest news on Inhibikase Therapeutics stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Inhibikase Therapeutics performance
Categories: All
Monday, June 30, 2025
Friday, June 27, 2025
Friday, June 20, 2025
Wednesday, May 14, 2025
Monday, April 14, 2025
Friday, March 28, 2025
Thursday, March 27, 2025
Tuesday, February 18, 2025
Wednesday, February 12, 2025
Thursday, January 30, 2025
Friday, November 15, 2024
Thursday, November 14, 2024
Friday, November 08, 2024
Thursday, October 24, 2024
Monday, October 14, 2024
Thursday, October 10, 2024
Wednesday, October 09, 2024
- Dow Surges 350 Points; US Crude Oil Stocks Increase
- 12 Health Care Stocks Moving In Wednesday's Intraday Session
- Crude Oil Edges Lower; US Wholesale Inventories Rise 0.1% In August
- Why Inhibikase Therapeutics (IKT) Stock Is Up 50% Today
- Dow Jumps Over 100 Points; Helen Of Troy Posts Upbeat Q2 Results
- Inhibikase Therapeutics shares are trading hi...
- Inhibikase Therapeutics Announces Pricing Of ...
